Journals of Gerontology Series A: Biological Sciences and Medical Sciences Large Type Edition
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Marcantonio, E. R.
Right arrow Articles by Inouye, S. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Marcantonio, E. R.
Right arrow Articles by Inouye, S. K.
The Journals of Gerontology Series A: Biological Sciences and Medical Sciences 61:1281-1286 (2006)
© 2006 The Gerontological Society of America

SPECIAL SECTION

Review Article

Serum Biomarkers for Delirium

Edward R. Marcantonio, James L. Rudolph, Deborah Culley, Gregory Crosby, David Alsop and Sharon K. Inouye

1 Division of General Medicine and Primary Care, 2 Department of Radiology, and 3 Division of Gerontology, Beth Israel Deaconess Medical Center, Boston, Massachusetts.
4 Department of Anesthesia and 5 Division of Aging, Brigham and Women's Hospital, Boston, Massachusetts.
6 Aging Brain Center, Hebrew SeniorLife, Boston, Massachusetts.
7 Geriatrics Research, Education and Clinical Center, Boston Veteran's Administration Medical Center, Massachusetts.
8 Harvard Medical School, Boston, Massachusetts.

Address correspondence to Edward R. Marcantonio, MD, SM, Beth Israel Deaconess Medical Center, 1309 Beacon St., Rm. 218, Brookline, MA 02446. E-mail: emarcant{at}bidmc.harvard.edu

This narrative review examines serum biomarkers for the diagnosis and monitoring of delirium. Serum biomarkers for delirium fall into three major groups: 1) those that are present or elevated prior to disease onset—risk markers, 2) those that rise with onset and fall with recovery—disease markers, and 3) those that rise in proportion to the consequences of disease—end products. As risk markers, we examine serum chemistries and genetic risk markers. As disease markers, we examine serum anticholinergic activity, amino acids, melatonin, cytokines, cortisol, and gene expression. As end products of delirium, we examine markers of neuronal injury. Finally, we discuss methodological and biostatistical considerations for future biomarker studies. Identifying accurate biomarkers for delirium may shed further light into its pathophysiology and on the interrelationship between delirium and dementia.




This article has been cited by other articles:


Home page
 J. Gerontol. A Biol. Sci. Med. Sci.Home page
J. L. Rudolph, B. Ramlawi, G. A. Kuchel, J. E. McElhaney, D. Xie, F. W. Sellke, K. Khabbaz, S. E. Levkoff, and E. R. Marcantonio
Chemokines Are Associated With Delirium After Cardiac Surgery
J. Gerontol. A Biol. Sci. Med. Sci., February 1, 2008; 63(2): 184 - 189.
[Abstract] [Full Text] [PDF]

Home page
 Age AgeingHome page
S. Speciale, G. Bellelli, F. Guerini, and M. Trabucchi
C-reactive protein levels and delirium in a rehabilitation ward
Age Ageing, January 1, 2008; 37(1): 122 - 123.
[Full Text] [PDF]

Home page
 J. Gerontol. A Biol. Sci. Med. Sci.Home page
S. K. Inouye and L. Ferrucci
Introduction: Elucidating the Pathophysiology of Delirium and the Interrelationship of Delirium and Dementia
J. Gerontol. A Biol. Sci. Med. Sci., December 1, 2006; 61(12): 1277 - 1280.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
All GSA journals The Gerontologist
Journals of Gerontology Series B: Psychological Sciences and Social Sciences
Copyright © 2006 by The Gerontological Society of America.